TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.

Amy S Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.